ReachMD halka açık
[search 0]
Daha fazla

Download the App!

show episodes
 
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
 
Loading …
show series
 
CME credits: 0.25 Valid until: 23-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/alloimmune-thrombocytopenia-in-the-fetus-and-newborn/13909/ Program Chairman: Roberto Romero, MD, DMedSci Chief, Perinatology Research Branch Division of Maternal-Fetal Medicine and Obstetrics Division of Intramural Research NICHD/NIH/DHHS Editor-in-…
 
CME credits: 0.25 Valid until: 22-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/medical-management-of-uterine-fibroids-gnrh-antagonists/14144/ GnRH antagonists are revolutionizing the medical management of uterine fibroids. Drs. Al-Hendy and Shulman discuss how medical myomectomy with GnRH antagonists is revolutionizing care by …
 
CME credits: 0.25 Valid until: 21-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/emerging-evidence-in-second-line-and-potential-considerations-in-first-line-agc-and-gej-cancers/14038/ HER2 is an essential biomarker to be assessed in all patients with gastric/GEJ cancer. Its importance is not only related to its role as a therapeu…
 
CME credits: 0.25 Valid until: 18-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/direct-from-the-heart-failure-clinic-novel-device-therapy-for-patients-with-hfref/14473/ Despite the use of guideline-directed medical therapy (GDMT), many heart failure (HF) patients may experience worsening symptoms and disease progression. There i…
 
CME credits: 0.25 Valid until: 16-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/the-critical-role-of-addressing-patient-fertility-desire-in-the-treatment-of-uterine-fibroids-and-endometriosis/14143/ Fertility preservation is a significant clinical concern for all women of reproductive age diagnosed with endometriosis or uterine …
 
CME credits: 0.50 Valid until: 15-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/trop2-adcs-for-metastatic-nsclc-setting-the-stage-for-future-use/14416/ Antibody-drug conjugates (ADCs) have promising clinical data in the treatment of advanced non-small cell lung cancer. Listen in as Drs. Benjamin Levy, Rebecca Heist, and Peter Il…
 
CME credits: 0.50 Valid until: 15-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/immune-based-advances-in-gastric-esophageal-and-gastroesophageal-junction-cancers/14481/ Recent immunotherapy approvals for gastric, esophageal, and gastroesophageal junction cancers have transformed the treatment landscape. Listen in as Drs. Eric Va…
 
CME credits: 0.25 Valid until: 11-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/personalizing-treatment-in-cushings-disease/14397/ Cushing’s disease is complex, and individualized approaches require the consideration of many patient factors. You and your patient also need to know what to expect in terms of therapeutic response a…
 
CME credits: 0.50 Valid until: 04-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/advances-in-the-care-of-patients-with-msi-hdmmr-or-her2-colorectal-cancers/14480/ In this chapterized panel discussion, Drs. Aparna Parikh, Dustin Deming, and Scott Kopetz take us through NCCN recommended guidelines and best practices for identifying…
 
CME credits: 0.25 Valid until: 02-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/evaluating-your-current-options-in-the-treatment-of-nsclc-with-metex14-skipping-mutations/14089/ Take a deep dive into current and ongoing clinical trials related to MET inhibitors and discover the key distinctions between these agents, such as dosin…
 
CME credits: 0.25 Valid until: 02-11-2023 Claim your CME credit at https://reachmd.com/programs/cme/patient-centered-discussions-and-shared-decision-making-in-the-management-of-nsclc-with-metex14-skipping-mutations/14088/ Join us as Dr. Jyoti Patel illustrates her approach to treating a 75-year-old patient who was recently diagnosed with stage IV N…
 
CME credits: 0.50 Valid until: 30-03-2023 Claim your CME credit at https://reachmd.com/programs/cme/menopause-matterslets-start-paying-attention-to-racial-and-ethnic-differences-current-and-emerging-treatment-approaches/14519/ This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and …
 
CME credits: 0.50 Valid until: 30-03-2023 Claim your CME credit at https://reachmd.com/programs/cme/menopause-matterslets-start-paying-attention-to-racial-and-ethnic-differences-overview-of-disparities/14518/ This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and ethnic backgrounds…
 
CME credits: 0.50 Valid until: 30-03-2023 Claim your CME credit at https://reachmd.com/programs/cme/menopause-matterslets-start-paying-attention-to-racial-and-ethnic-differences-addressing-patient-needs/14520/ This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and ethnic background…
 
CME credits: 0.25 Valid until: 31-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/heart-failure-grand-rounds-3-things-you-need-to-know-about-cardiac-contractility-modulation/14396/ Cardiac contractility modulation (CCM) is a novel, approved, implantable therapy that significantly improves heart failure symptoms, exercise tolerance…
 
CME credits: 0.25 Valid until: 31-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/retina-clinic-emerging-treatment-options-in-diabetic-retinopathy/13985/ Can we apply the new, more durable treatments in diabetic macular edema and neovascular age-related macular degeneration to the treatment of our patients with diabetic retinopath…
 
CME credits: 0.25 Valid until: 31-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/why-icis-have-revolutionized-cancer-care/14456/ Immune checkpoint inhibitors, or ICIs, have improved the prognosis for patients with many different types of cancer. Drs. Forde and García-Foncillas outline current biomarkers and the importance of test…
 
CME credits: 0.25 Valid until: 28-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/treatment-of-cllsll-with-btkis-whole-patient-approaches/14148/ The disease continuum for chronic lymphocytic leukemia (CLL) has rapidly evolved to include non-chemotherapy-based regimens that disrupt B cell receptor signaling. The increased availabil…
 
CME credits: 0.25 Valid until: 27-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/targeting-the-fc-receptor-pathway-to-treat-red-blood-cell-alloimmunization/13908/ Program Chairman: Roberto Romero, MD, DMedSci Chief, Perinatology Research Branch Division of Maternal-Fetal Medicine and Obstetrics Division of Intramural Research NIC…
 
CME credits: 0.25 Valid until: 25-10-2023 Claim your CME credit at https://reachmd.com/programs/project-oncology/management-tools-for-early-stage-lung-cancer/13232/ Lung cancer screenings have shown to be effective in detecting lung cancer earlier. So what are the current guidelines? To discuss this question and give their own experiences with lung…
 
CME credits: 1.00 Valid until: 19-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/challenging-cases-in-ckd-anemia-the-kidneys-and-heart-as-linked-parts/14128/ Anemia in chronic kidney disease (CKD) is persistently undermanaged because current treatments have been linked with an increased risk for major cardiovascular events. They …
 
CME credits: 0.25 Valid until: 19-10-2023 Claim your CME credit at https://reachmd.com/programs/cme/factors-that-delay-diagnosis-of-uterine-fibroids-and-endometriosis-the-demographic-divide/14142/ Join Drs. Linda Bradley and Lee Shulman as they discuss factors contributing to disparities in care for patients with endometriosis and/or uterine fibroi…
 
Loading …

Hızlı referans rehberi

Google login Twitter login Classic login